Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000038

CEO bought 111,000 shares at an average $0.01 ($1,256)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2019-06-05 Purchase : show line 1 in the form +20,000 $0.01 $224 24,211,097 D
2019-06-05 Purchase : show line 2 in the form +20,000 $0.01 $224 24,231,097 D
2019-06-05 Purchase : show line 3 in the form +20,000 $0.01 $224 24,251,097 D
2019-06-06 Purchase : show line 4 in the form +5,000 $0.01 $58 24,256,097 D
2019-06-06 Purchase : show line 5 in the form +15,000 $0.01 $168 24,271,097 D
2019-06-06 Purchase : show line 6 in the form +2,000 $0.01 $23 24,273,097 D
2019-06-06 Purchase : show line 7 in the form +2,000 $0.01 $23 24,275,097 D
2019-06-06 Purchase : show line 8 in the form +2,000 $0.01 $24 24,277,097 D
Open-market purchases · 111,000 sh · avg $0.01 · $1,256
Loading xslF345X03/primary_doc.xml…